Results 1 to 10 of about 49,828 (259)

Sustained glucagon-like peptide-1 receptor agonist treatment improves glycemic control and reduces all-cause mortality compared to dipeptidyl peptidase-4 inhibitors: A real-world target trial emulation in type 2 diabetes. [PDF]

open access: yesDiabetes Obes Metab
Sørensen KK   +15 more
europepmc   +1 more source

PARP inhibitor-induced anti-tumour chemokine response is suppressed by dipeptidyl peptidase 4 (DPP4) in ovarian cancer. [PDF]

open access: yesBr J Cancer
Stange C   +7 more
europepmc   +1 more source

Association of Dipeptidyl Peptidase-4 Inhibitors with Glaucoma Risk in Patients with Type 2 Diabetes: A Nationwide Cohort Study. [PDF]

open access: yesOphthalmol Sci
Lu YA   +10 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Home - About - Disclaimer - Privacy